We have limited Portuguese content available. View Portuguese content.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech
en
Read more

Getting Ready for the Recovery in Healthcare M&A

Companies willing to invest shrewdly in the downturn will emerge from it stronger.
Explore the full report

M&A Report 2022

Bain's fourth annual Global M&A Report looks at what the best companies did to win in a white-hot market.
Tags
Tags

How We've Helped Clients

Divestiture adds value to parent, subsidiary

See more related case studies

Recharging the pharmaceutical sales model

See more related case studies

Pharma go-to-market strategy

See more related case studies

Quer saber mais?

Ajudamos líderes do mundo todo a lidar com desafios e oportunidades cruciais para sua organização. Juntos, criamos mudanças e resultados duradouros

Contact Bain

How can we help you?

See all offices